BioCentury
ARTICLE | Politics, Policy & Law

Trump administration debate over malaria drugs for COVID-19 illustrates White House conflicts

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 6, 2020 11:44 PM UTC

The debate within the Trump administration over the use of hydroxychloroquine to treat COVID-19, previously reported only through leaks, broke into public view over the weekend and Monday, illustrating the White House’s chaotic decision-making processes.

Peter Navarro, director of the White House Office of Trade and Manufacturing Policy, told CNN television Monday that he strongly supports use of hydroxychloroquine both as a treatment for and prophylactic against COVID-19. “The scientific studies I have seen point to the possibility that it has both therapeutic efficacy as well as possible prophylactic efficacy.”...